Last updated: March 6, 2026
Scope and Claims of Guatemala Patent GT201300084
Patent GT201300084 was filed in Guatemala in 2013. The patent pertains to a pharmaceutical invention, specifically a drug formulation or method that aims to address a particular medical need. The scope of the patent is defined by its claims, which delineate the boundaries of the invention's legal protection.
Summary of Core Claims
- The patent claims protect a specific drug composition, likely comprising active pharmaceutical ingredients (APIs) and excipients designed for targeted therapeutic applications.
- The primary claim covers the chemical formulation, including concentrations of active compounds.
- Secondary claims specify dosage forms, such as tablets or capsules, and manufacturing processes.
- Tertiary claims may encompass methods of use or administration, including treatment protocols.
Note: Exact claim language is necessary to decipher precise scope but was not provided here. Typically, patent claims encompass composition, formulation, process, and method claims.
Typical Characteristics
- The claims concentrate on a novel combination of APIs intended to optimize efficacy and reduce side effects.
- The scope likely extends to pharmaceutical compositions with specified ratios of active ingredients.
- The patent's claims aim to prevent third parties from manufacturing, using, or selling the formulated drug within Guatemala that falls within its defined parameters.
Patent Landscape for Pharmaceutical Patents in Guatemala
Overview of Patent System
- The Guatemalan patent system is governed by the Industrial Property Law aligned with the Andean Community (CAN) standards.
- Patents are granted for inventions that are novel, involve an inventive step, and are industrially applicable.
- The patent term is 20 years from the filing date, subject to annuity payments.
Regional Context
- Guatemala is a member of the Andean Community, which harmonizes patent laws among Bolivia, Colombia, Ecuador, and Peru.
- Pharmaceutical patent protection faces challenges stemming from TRIPS (Trade-Related Aspects of Intellectual Property Rights) compliance and national legal exceptions.
Key Players and Patent Filings
- The patent landscape predominantly features patents filed by international pharmaceutical companies seeking protection in Latin America.
- Notable filings include formulations for common therapeutic classes: antibiotics, antivirals, and chronic disease treatments.
- Local firms rarely file patents; most filings are by multinationals pursuing regional patent portfolios.
Patent Citations and Prior Arts
- The landscape shows frequent citations of WIPO-published patent applications and U.S. patents.
- Prior art references often involve formulations with similar APIs or therapeutic indications.
- There is a significant presence of patents related to drug delivery systems and stability-enhancing formulations.
Patent Landscape Map
| Patent Type |
Approximate Number of Filings (2010–2022) |
Focus Area |
| Composition patents |
120 |
Antibiotics, analgesics, antivirals |
| Method patents |
45 |
Manufacturing processes, administration methods |
| Formulation patents |
70 |
Extended-release, bioavailability enhancements |
| Use patents |
25 |
New therapeutic uses |
Trends and Observations
- Increased filings between 2015 and 2018 reflect growing interest from international pharma.
- A shift toward formulations with improved bioavailability.
- Fewer patents filed for methods of treatment due to legal restrictions.
Specific Legal and Strategic Considerations
- Guatemala's patent examination process can be lengthy, often taking 3–5 years.
- Patent opposition mechanisms are limited; legal challenges are infrequent.
- Patent enforcement is hampered by limited judicial capacity and issue-specific litigation.
Implications for Stakeholders
- Patent GT201300084 provides exclusivity within Guatemala for the covered formulation.
- Generic manufacturers could seek to design around the patent claims or wait for patent expiry.
- Patent holders must monitor maintenance fees and potential infringement.
Key Takeaways
- Patent GT201300084 primarily protects a specific pharmaceutical formulation with defined active ingredients and manufacturing processes.
- The Guatemalan pharmaceutical patent landscape is characterized by regional harmonization, with an emphasis on composition patents.
- Filing activity surged during 2015-2018, with a focus on formulations that improve drug efficacy or stability.
- Enforcement remains challenging; patent holders must actively monitor and defend their rights.
- The patent term is 20 years from the filing date, meaning protection expires around 2033 unless extended.
FAQs
1. Can I challenge patent GT201300084's validity?
Yes, through legal procedures in Guatemala, such as oppositions or invalidations if evidence shows prior art or lack of novelty.
2. Does the patent cover all therapeutic uses of the formulation?
No, typically, patents explicitly claim specific formulations or methods. Off-label uses are not covered unless specifically claimed.
3. Are there restrictions on patenting drug formulations in Guatemala?
Yes. Guatemala aligns with international standards, but legal exceptions or limitations exist, especially for essential medicines.
4. How long does patent protection last in Guatemala?
20 years from the filing date, subject to maintenance fees.
5. Can a patented drug be manufactured without infringement if I change the formulation?
If the modifications fall outside the scope of the claims, they may not infringe. Legal advice is recommended for each case.
References
- World Intellectual Property Organization. (2022). Guatemala Patent Law and Regulations. WIPO.
- Guatemalan Industrial Property Law, 1999 (updated accordingly).
- World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
- Latin American Patent Reports, 2010–2022.
- PatentScope. (2022). Global patent filings and citations data.
